<i>Pneumocystis jirovecii</i> pneumonia in an immunocompetent patient recovered from COVID-19
Giulio Viceconte, Antonio Riccardo Buonomo, Amedeo Lanzardo, Biagio Pinchera, Emanuela Zappulo, Riccardo Scotto, Nicola Schiano Moriello, Maria Vargas, Carmine Iacovazzo, Giuseppe Servillo, Ivan Gentile, “Federico II” COVID-19 Team
Abstract
BACKGROUND: pneumonia (PJP) as co-infections in immunocompromised patients. We describe the first case of PJP in an immunocompetent patient who recovered from COVID-19 pneumonia. CASE DESCRIPTION: (BID) was started, with improvement of clinical, biochemical and radiological conditions. CONCLUSIONS: COVID-19 patients may have multiple risk factors for development of PJP, in particular lymphopaenia and use of steroids. PJP must be ruled out with direct microbiological methods in patients presenting with radiologic and clinical features of possible or probable PJP, even in immunocompetent hosts.